主頁 > Biological effectiveness of antiproton annihilation |
Article | |
Title | Biological effectiveness of antiproton annihilation |
Author(s) | Maggiore, C J (Pbar Medical, Newport Beach) ; Agazaryan, N (UCLA, Los Angeles (main)) ; Bassler, N (Aarhus U. (main)) ; Blackmore, E (TRIUMF) ; Beyer, G (Geneva, U. Medical Ctr.) ; De Marco, J J (UCLA, Los Angeles (main)) ; Doser, Michael (CERN) ; Gruhn, Charles R (Pbar Medical, Newport Beach) ; Holzscheiter, M H (Pbar Medical, Newport Beach) ; Ichioka, T (Aarhus U. (main)) ; Iwamoto, K S (UCLA, Los Angeles (main)) ; Knudsen, H V (Aarhus U. (main)) ; Landua, Rolf (CERN) ; McBride, W H (UCLA, Los Angeles (main)) ; Møller, S P (Aarhus U. (main)) ; Petersen, J (Aarhus Kommunehospital) ; Smathers, J B (UCLA, Los Angeles (main)) ; Skarsgard, L D (British Columbia Cancer Research, Vancouver) ; Solberg, T (UCLA, Los Angeles (main)) ; Uggerhøj, U (Aarhus U. (main)) ; Withers, H R (UCLA, Los Angeles (main)) ; Wouters, B G (U.Maastricht) |
Publication | 2004 |
In: | Nucl. Instrum. Methods Phys. Res., B 214 (2004) 181-185 |
In: | 8th International Conference on Low-Energy Antiproton Physics, Yokohama, Japan, 3 - 7 Mar 2003, pp.181-185 |
DOI | 10.1016/S0168-583X(03)01781-6 |
Subject category | Health Physics and Radiation Effects |
Accelerator/Facility, Experiment | CERN AD ; ACE AD-4 |
Abstract | A new experiment, AD-4/ACE (antiproton cell experiment), has been approved by the CERN Research Board. The experiment is scheduled to begin taking data in June and continue through the 2003 run cycle. The experiment is designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in "biological dose" in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The background, description, and status of the experiment are given. |